BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 19380819)

  • 41. High frequency of viral protein expression in human T cell lymphotropic virus type 1-infected peripheral blood mononuclear cells.
    Hanon E; Asquith RE; Taylor GP; Tanaka Y; Weber JN; Bangham CR
    AIDS Res Hum Retroviruses; 2000 Nov; 16(16):1711-5. PubMed ID: 11080815
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Immunopathogenesis and treatment of the myelopathy associated to the HTLV-I virus].
    Carod-Artal FJ
    Rev Neurol; 2009 Feb 1-15; 48(3):147-55. PubMed ID: 19206063
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Programmed death-1 (PD-1)/PD-1 ligand pathway-mediated immune responses against human T-lymphotropic virus type 1 (HTLV-1) in HTLV-1-associated myelopathy/tropical spastic paraparesis and carriers with autoimmune disorders.
    Kozako T; Yoshimitsu M; Akimoto M; White Y; Matsushita K; Soeda S; Shimeno H; Kubota R; Izumo S; Arima N
    Hum Immunol; 2011 Nov; 72(11):1001-6. PubMed ID: 21851845
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The role of CTLs in persistent viral infection: cytolytic gene expression in CD8+ lymphocytes distinguishes between individuals with a high or low proviral load of human T cell lymphotropic virus type 1.
    Vine AM; Heaps AG; Kaftantzi L; Mosley A; Asquith B; Witkover A; Thompson G; Saito M; Goon PK; Carr L; Martinez-Murillo F; Taylor GP; Bangham CR
    J Immunol; 2004 Oct; 173(8):5121-9. PubMed ID: 15470056
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Loss of the ex vivo but not the reinducible CD8+ T-cell response to Tax in human T-cell leukemia virus type 1-infected patients with adult T-cell leukemia/lymphoma.
    Arnulf B; Thorel M; Poirot Y; Tamouza R; Boulanger E; Jaccard A; Oksenhendler E; Hermine O; Pique C
    Leukemia; 2004 Jan; 18(1):126-32. PubMed ID: 14574331
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The IL-18, IL-12, and IFN-γ expression in HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) patients, HTLV-1 carriers, and healthy subjects.
    Bidkhori HR; Hedayati-Moghaddam MR; Mosavat A; Valizadeh N; Tadayon M; Ahmadi Ghezeldasht S; Rafatpanah H; Rezaee SA
    J Neurovirol; 2020 Jun; 26(3):338-346. PubMed ID: 32270468
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The influence of HLA class I alleles and heterozygosity on the outcome of human T cell lymphotropic virus type I infection.
    Jeffery KJ; Siddiqui AA; Bunce M; Lloyd AL; Vine AM; Witkover AD; Izumo S; Usuku K; Welsh KI; Osame M; Bangham CR
    J Immunol; 2000 Dec; 165(12):7278-84. PubMed ID: 11120862
    [TBL] [Abstract][Full Text] [Related]  

  • 48. High activated and memory cytotoxic T-cell responses to HTLV-1 in healthy carriers and patients with tropical spastic paraparesis.
    Daenke S; Kermode AG; Hall SE; Taylor G; Weber J; Nightingale S; Bangham CR
    Virology; 1996 Mar; 217(1):139-46. PubMed ID: 8599198
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Target epitopes of HTLV-1 recognized by class I MHC-restricted cytotoxic T lymphocytes in patients with myelopathy and spastic paraparesis and infected patients with autoimmune disorders.
    Kozako T; Akimoto M; Toji S; White Y; Suzuki S; Arima T; Suruga Y; Matsushita K; Shimeno H; Soeda S; Kubota R; Izumo S; Uozumi K; Arima N
    J Med Virol; 2011 Mar; 83(3):501-9. PubMed ID: 21264872
    [TBL] [Abstract][Full Text] [Related]  

  • 50. CADM1/TSLC1 Identifies HTLV-1-Infected Cells and Determines Their Susceptibility to CTL-Mediated Lysis.
    Manivannan K; Rowan AG; Tanaka Y; Taylor GP; Bangham CR
    PLoS Pathog; 2016 Apr; 12(4):e1005560. PubMed ID: 27105228
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Human T-cell lymphotropic virus type I (HTLV-I) proviral DNA viral load among asymptomatic patients and patients with HTLV-I-associated myelopathy/tropical spastic paraparesis.
    Montanheiro PA; Oliveira AC; Posada-Vergara MP; Milagres AC; Tauil C; Marchiori PE; Duarte AJ; Casseb J
    Braz J Med Biol Res; 2005 Nov; 38(11):1643-7. PubMed ID: 16258633
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Human T cell lymphotropic virus type 1 (HTLV-1) proviral load of HTLV-associated myelopathy/tropical spastic paraparesis (HAM/TSP) patients according to new diagnostic criteria of HAM/TSP.
    Grassi MF; Olavarria VN; Kruschewsky Rde A; Mascarenhas RE; Dourado I; Correia LC; de Castro-Costa CM; Galvão-Castro B
    J Med Virol; 2011 Jul; 83(7):1269-74. PubMed ID: 21567429
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Human T cell lymphotropic virus (HTLV) type-1-specific CD8+ T cells: frequency and immunodominance hierarchy.
    Goon PK; Biancardi A; Fast N; Igakura T; Hanon E; Mosley AJ; Asquith B; Gould KG; Marshall S; Taylor GP; Bangham CR
    J Infect Dis; 2004 Jun; 189(12):2294-8. PubMed ID: 15181578
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Expression of TSLC1 in patients with HAM/TSP.
    Takenouchi N; Tanaka M; Sato T; Yao J; Fujisawa JI; Izumo S; Kubota R; Matsuura E
    J Neurovirol; 2020 Jun; 26(3):404-414. PubMed ID: 32285300
    [TBL] [Abstract][Full Text] [Related]  

  • 55. HTLV-I specific IFN-gamma+ CD8+ lymphocytes correlate with the proviral load in peripheral blood of infected individuals.
    Kubota R; Kawanishi T; Matsubara H; Manns A; Jacobson S
    J Neuroimmunol; 2000 Jan; 102(2):208-15. PubMed ID: 10636490
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Universal cytotoxic activity of a HTLV-1 Tax-specific T cell clone from an HLA-A*24:02⁺ patient with adult T-cell leukemia against a variety of HTLV-I-infected T-cells.
    Tanaka Y; Yamazaki R; Terasako-Saito K; Nakasone H; Akahoshi Y; Nakano H; Ugai T; Wada H; Yamasaki R; Ishihara Y; Kawamura K; Sakamoto K; Ashizawa M; Sato M; Kimura S; Kikuchi M; Kako S; Kanda J; Tanihara A; Nishida J; Kanda Y
    Immunol Lett; 2014; 158(1-2):120-5. PubMed ID: 24389072
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Abundant tax protein expression in CD4+ T cells infected with human T-cell lymphotropic virus type I (HTLV-I) is prevented by cytotoxic T lymphocytes.
    Hanon E; Hall S; Taylor GP; Saito M; Davis R; Tanaka Y; Usuku K; Osame M; Weber JN; Bangham CR
    Blood; 2000 Feb; 95(4):1386-92. PubMed ID: 10666215
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Astrocyte-specific expression of human T-cell lymphotropic virus type 1 (HTLV-1) Tax: induction of tumor necrosis factor alpha and susceptibility to lysis by CD8+ HTLV-1-specific cytotoxic T cells.
    Méndez E; Kawanishi T; Clemens K; Siomi H; Soldan SS; Calabresi P; Brady J; Jacobson S
    J Virol; 1997 Dec; 71(12):9143-9. PubMed ID: 9371571
    [TBL] [Abstract][Full Text] [Related]  

  • 59. HTLV-1 tax specific CD8+ T cells express low levels of Tim-3 in HTLV-1 infection: implications for progression to neurological complications.
    Ndhlovu LC; Leal FE; Hasenkrug AM; Jha AR; Carvalho KI; Eccles-James IG; Bruno FR; Vieira RG; York VA; Chew GM; Jones RB; Tanaka Y; Neto WK; Sanabani SS; Ostrowski MA; Segurado AC; Nixon DF; Kallas EG
    PLoS Negl Trop Dis; 2011 Apr; 5(4):e1030. PubMed ID: 21541358
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Existence of escape mutant in HTLV-I tax during the development of adult T-cell leukemia.
    Furukawa Y; Kubota R; Tara M; Izumo S; Osame M
    Blood; 2001 Feb; 97(4):987-93. PubMed ID: 11159527
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.